Erysipelas natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 15: Line 15:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
 
[[Category:Dermatology]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 21:24, 5 December 2012

Erysipelas Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Erysipelas from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Erysipelas natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Erysipelas natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Erysipelas natural history, complications and prognosis

CDC on Erysipelas natural history, complications and prognosis

Erysipelas natural history, complications and prognosis in the news

Blogs on Erysipelas natural history, complications and prognosis

Directions to Hospitals Treating Erysipelas

Risk calculators and risk factors for Erysipelas natural history, complications and prognosis

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Natural History, Complications and Prognosis

  • Spread of infection to other areas of body through the bloodstream (bacteremia), including septic arthritis and infective endocarditis (heart valves).
  • Septic shock.
  • Recurrence of infection – Erysipelas can recur in 18-30% of cases even after antibiotic treatment.
  • Lymphatic damage
  • Necrotizing fasciitis -- AKA "the flesh-eating bug." A potentially-deadly exacerbation of the infection if it spreads to deeper tissue.

References

Template:WH Template:WS